glp 1 oral tablet FDA approves Foundayo, an GLP-1 alternative to Wegovy and Ozempic FDA Approved: Orforglipron (Foundayo) —

Although the strongest effect of delayed gastric emptying occurs within these initial 20 weeks for most patients

These molecules offer improved patient convenience, reduced injection dependency, and the ability to combine with other therapies

120 It has been demonstrated that genetic ablation of GIPR and GLP-1R either individually or at the same time in mice results in impaired insulin secretion confirming that both GIP and GLP-1 mediate the incretin effect

we can help people lose weight

Microdosing supports gradual adaptation rather than shock to the system

only 25.3% of adults have heard of MyPlate and only 8.3% try to follow the recommendations, implying more education on well-balanced meals is needed (34)